Devax Inc.

MedCity Influencers

U.K. company buys Axxess bifurcation stents for $5.7M

Biosensors International Group Ltd. has acquired Devax Inc.’s Axxess bifurcation-stent assets in a deal worth $5.7 million. The United Kingdom-based company said the drug-eluting stent is a “natural complement” to its existing product portfolio. The device received CE Mark approval in August 2010. “We have a large and growing base of clinical data demonstrating the […]